Συγγραφείς:
Sachanas, S.
Pangalis, G.A.
Kalpadakis, C.
Levidou, G.
Yiakoumis, X.
Moschogiannis, M.
Kyrtsonis, M.-C.
Vassilakopoulos, T.P.
Tsirkinidis, P.
Siakantaris, M.
Spiliadi, C.
Karagianni, E.
Korkolopoulou, P.
Rontogianni, D.
Papadaki, H.
Panayiotidis, P.
Angelopoulou, M.
Λέξεις-κλειδιά:
chlorambucil; rituximab, Article; cancer diagnosis; cancer grading; cancer staging; cancer therapy; gastrointestinal endoscopy; human; lymphadenopathy; marginal zone lymphoma; nodal marginal zone lymphoma; phase 2 clinical trial (topic); priority journal; recurrence free survival; relapse; splenomegaly; adjuvant chemotherapy; cancer grading; immunohistochemistry; immunophenotyping; Lymphoma, B-Cell, Marginal Zone; pathology; treatment outcome, Chemotherapy, Adjuvant; Humans; Immunohistochemistry; Immunophenotyping; Lymphoma, B-Cell, Marginal Zone; Neoplasm Grading; Neoplasm Staging; Treatment Outcome